Enterprise League logo
Wellington Partners Logo

Wellington Partners

Munich, Germany · Finance and Banking

Do your work at Wellington Partners?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

#venture capital

#private equity

#technology

#life sciences

#digital media

#software

#resource efficiency

#medtech

#diagnostics

#therapeutics

Wellington Partners is a Finance and Banking company based in Munich, Germany, founded in 1998, with 20-30 employees. Wellington Partners's profile is verified on Enterprise League.

Overview

Wellington Partners is a leading European venture capital firm specializing in early- and growth-stage life science companies. Based in Munich, Germany, and with offices in London, Zurich, and Palo Alto, we invest in disruptive innovations across sectors including Therapeutics, Medical Devices, Diagnostics, Digital Health, and Industrial Biotechnology. With over 15 years of experience, we provide funding and strategic guidance to entrepreneurs seeking to become global leaders. We focus on backing companies with breakthrough technologies and strong leadership, fostering a collaborative environment to unlock potential and drive impactful advancements in healthcare. Our current fund, WPLS V, represents a significant investment, enabling us to support the growth ambitions of Europe’s most promising start-ups. We are committed to transforming innovative ideas into impactful medical practices of tomorrow.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@wellington-partners.com

Munich, Germany, Tuerkenstrasse 5

+3

Founded

1998

Company Type

Partnership

Employees

20-30

Categories

Impact Investing
Investment
Venture Capital

Keywords

#venture capital

#private equity

#technology

#life sciences

#digital media

#software

#resource efficiency

#medtech

#diagnostics

#therapeutics

Awards

2026 OpenSee all

Products

Default Product Image
Confo Therapeutics
Venture Capital

Confo Therapeutics is a drug discovery platform focused on high-value GPCR targets. Wellington Partners supports Confo's development of innovative therapies for a range of medical conditions.

N/A


Services

Default Product Image
Wellington Partners Funds
Venture Capital

Wellington Partners offers access to its current fund, WPLS V, a substantial investment vehicle designed to support the growth of early-stage life science companies. This fund provides capital and strategic guidance to entrepreneurs seeking to scale their businesses and achieve market leadership.

N/A

Companies teams usually look at after Wellington Partners

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.